What is Disc Medicine, Inc. (IRON) stock price today?

Disc Medicine, Inc. (IRON) is currently trading at $62.06, up 2.12% today.

What is IRON P/E ratio?

Disc Medicine, Inc.'s P/E ratio is -9.92. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is IRON return on equity (ROE)?

Disc Medicine, Inc.'s return on equity (ROE) is -37.17%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Disc Medicine, Inc.'s market cap?

Disc Medicine, Inc. has a market capitalization of $2.38B.

NASDAQ · Biotechnology

Disc Medicine, Inc. (IRON) Stock

$62.06 +2.12% NASDAQ: IRON Healthcare

Valuation

Metric	Value
Price	$62.06
Market Cap	$2.38B
P/E Ratio	-9.92
P/B Ratio	3.93
P/S Ratio	0.00
EPS (TTM)	$-6.64
52-Week High	$99.50
52-Week Low	$40.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-37.17%
ROA	-33.45%
ROCE	-38.21%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.09
Current Ratio	24.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-31.0M	$-47.0M	$-91.0M	$-130.0M	$-236.0M
Net Profit	$-36.0M	$-47.0M	$-76.0M	$-109.0M	$-212.0M
EPS	$-44.88	$-45.05	$-3.42	$-3.96	$-6.01
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$92.0M	$200.0M	$368.0M	$497.0M	$807.0M
Total Liabilities	$157.0M	$24.0M	$23.0M	$53.0M	$67.0M
Cash	$88.0M	$195.0M	$360.0M	$192.0M	$91.0M
Borrowings	$7.0M	$1.0M	$2.0M	$30.0M	$2.0M

Latest News

Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 Disc Medicine Insider Sold Shares Worth $2,387,296, According to a Recent SEC Filing MT Newswires · Jun 23, 2026 Disc Medicine Insider Sold Shares Worth $1,287,801, According to a Recent SEC Filing MT Newswires · Jun 18, 2026 Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting GlobeNewswire · Jun 12, 2026 Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-28.0M	$-42.0M	$-73.0M	$-94.0M	$-180.0M
Investing Cash Flow	$0	$0	$0	$-293.0M	$-395.0M
Financing Cash Flow	$5.0M	$95.0M	$40.0M	$2.0M	$1.0M
Net Cash Flow	$62.0M	$107.0M	$166.0M	$-168.0M	$-101.0M
Free Cash Flow	$-28.0M	$-42.0M	$-74.0M	$-94.0M	$-181.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.27
EV / EBITDA	-10.24
FCF Yield	-7.86%
Quick Ratio	24.14
Interest Coverage	-75.81
Return 1Y	22.36%
Return 3Y	62.24%
Return 5Y	-47.85%

Ownership

Insiders Held7.78%

Institutions Held113.48%

Institutions Float Held123.05%

Institutional Holder	Shares	Report Date
FMR, LLC	5,586,894	2026-03-31
RA Capital Management, L.P.	2,450,221	2026-03-31
Blackrock Inc.	2,273,831	2026-03-31
Wellington Management Group, LLP	1,735,376	2026-03-31
State Street Corporation	1,698,244	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AGIOAgios Pharmaceuticals, Inc.	$31.81	-0.34%	-4.54	$1.90B	0.00%
COAGHemab Therapeutics Holdings, Inc. Common Stock	$31.62	+2.36%	-24.14	$1.48B	0.00%
DMRADamora Therapeutics, Inc.	$21.08	+2.53%	-0.17	$1.30B	0.00%
GERNGeron Corporation	$1.23	+0.41%	-12.04	$785.86M	0.00%
PTGXProtagonist Therapeutics, Inc.	$143.73	+2.73%	115.66	$9.24B	0.00%

About Disc Medicine, Inc.

Disc Medicine, Inc. (IRON) stock trades at $62.06 with a market capitalization of $2.38B. The stock is valued at a price-to-earnings (P/E) ratio of -9.92, price-to-book of 3.93, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $40.00 and $99.50, and currently trades 37.6% below its 52-week high.

On profitability, Disc Medicine, Inc. generates a return on equity (ROE) of -37.17%, return on capital employed of -38.21%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides